D-0280-2022 Class I Terminated

Recalled by Teligent Pharma, Inc. — Buena, NJ

FDA drug recall D-0280-2022 was initiated by Teligent Pharma, Inc. on Oct 12, 2021 and is designated Class I. Reason for recall: Superpotent Drug The recall status is terminated (terminated Jun 18, 2024). Affected quantity: 52,104 glass bottles.

Recall details

Product Type
Drugs
Report Date
Dec 22, 2021
Initiation Date
Oct 12, 2021
Termination Date
Jun 18, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
52,104 glass bottles

Product description

Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL glass bottles, Rx Only, Teligent Pharma Inc., Buena, NJ 08310, NDC 52565-009-50

Reason for recall

Superpotent Drug

Distribution pattern

Nationwide within the United States

Code information

Lot #: 13262, Exp. 03/2022; 14217, Exp. 08/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0280-2022
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0280-2022. Report a data issue: hello@regdatalab.com.